Valuation: Orum Therapeutics, Inc.

Market Cap 289B 217M 198M 183M 165M 311M 20.25B 323M 2.21B 872M 10.93B 813M 796M 34.52B P/E 2024 *
-
P/E 2025 -59.5x
Enterprise Value 182B 136M 124M 115M 104M 195M 12.74B 203M 1.39B 549M 6.88B 512M 501M 21.72B EV / Sales 2024 *
-
EV / Sales 2025 103,580x
Free-Float
83.68%
Yield 2024 *
-
Yield 2025 -
1 day-1.04%
1 week-10.63%
Current month-13.32%
1 month-20.95%
3 months-79.79%
6 months-80.41%
Current year-88.93%
1 week 13,180
Extreme 13180.00000000
16,380
1 month 13,180
Extreme 13180.00000000
17,560
Current year 13,180
Extreme 13180.00000000
146,600
1 year 13,180
Extreme 13180.00000000
146,600
3 years 13,180
Extreme 13180.00000000
146,600
5 years 13,180
Extreme 13180.00000000
146,600
10 years 13,180
Extreme 13180.00000000
146,600
Manager TitleAgeSince
Chief Executive Officer 52 16/08/2016
Director of Finance/CFO 44 22/10/2023
Chief Tech/Sci/R&D Officer - 04/01/2026
Director TitleAgeSince
Director/Board Member 52 16/08/2016
Director/Board Member 44 22/10/2023
Director/Board Member 55 31/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
21/02/25 Free

Founder

3,388,000 -
21/02/25 Free

Chief Financial Officer

10,000 -
21/02/25 Free

Director

60,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%-10.63%-76.66% - 219M
-1.34%-3.09%+56.10%+68.83% 66.37B
+0.59%-1.83%+8.98%+90.01% 58.86B
+0.54%+0.45%+25.96%+87.77% 55.22B
-2.34%-3.90%+10.90%+115.97% 47.21B
+0.09%-6.08%+18.67%+25.90% 42.45B
-2.58%+0.24%+18.54%+41.28% 36.44B
-1.76%-11.56%+126.44%+649.27% 35.19B
-0.17%-1.83%+82.46%+57.69% 32.66B
-1.69%-0.79%-40.58%+382.68% 26.73B
Average -0.97%-4.58%+23.08%+168.82% 40B
Weighted average by Cap. -0.84%-3.65%+34.16%+143.97%

Financials

2024 2025
Net sales 20.91B 15.68M 14.3M 13.23M 11.94M 22.48M 1.47B 23.36M 160M 63.14M 791M 58.84M 57.61M 2.5B 23.56M 17.68K 16.12K 14.91K 13.45K 25.34K 1.65M 26.34K 180K 71.17K 892K 66.32K 64.93K 2.82M
Net income -5.74B -4.31M -3.93M -3.63M -3.28M -6.17M -402M -6.42M -43.86M -17.34M -217M -16.16M -15.82M -686M -41.97B -31.49M -28.72M -26.55M -23.96M -45.13M -2.94B -46.9M -321M -127M -1.59B -118M -116M -5.01B
Net Debt -90.47B -67.87M -61.9M -57.23M -51.65M -97.27M -6.34B -101M -691M -273M -3.42B -255M -249M -10.81B -107B -80.35M -73.28M -67.75M -61.15M -115M -7.51B -120M -818M -323M -4.05B -301M -295M -12.8B
Projected Income Statement - Annual - Orum Therapeutics, Inc.
Logo Orum Therapeutics, Inc.
Orum Therapeutics Inc is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company is principally engaged in the research and development of new biopharmaceuticals for cancer and immune diseases based on its platforms.
Employees
24
Date Price Change Volume
18/11/26 ₩13,280.00 -1.04% 86,478
17/11/26 ₩13,420.00 -1.97% 84,153
16/11/26 ₩13,690.00 -8.73% 134,991
13/11/26 ₩15,000.00 +1.15% 188,280
12/11/26 ₩14,830.00 -0.20% 88,340
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A475830 Stock